SynBioBeta Speaker

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Jonathan Weinstein is a Principal Scientist for Protein Design Algorithms & AI at Scala Biodesign, where he contributes to the development of ScalaOS, a computational platform for engineering enzymes with improved stability, expression, and activity across varied industrial conditions, including cell-free manufacturing systems. His work focuses on algorithm development for protein design, with an emphasis on translating computational methods into enzymes that perform reliably at scale.Jonathan completed his PhD in computational protein design at the Weizmann Institute of Science in the laboratory of Sarel Fleishman, one of the field’s pioneering groups in native protein design and structure-based computational methods. His research philosophy centers on rigorous, structure-informed algorithm development applied directly to the demands of industrial enzyme deployment.

Sessions Featuring

Jonathan

This Year

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Breakout Session

•

3:30 PM

-

4:15 PM

Planetary Health

Biology Without Cells: The Rise of Cell-Free Biomanufacturing

Cell-free systems are redefining what’s possible in bioproduction. By bypassing the complexity of living cells, innovators can run enzyme cascades, prototype metabolic pathways, and produce high-value molecules with unmatched speed, precision, and purity. This new class of systems—from freeze-dried reactions to continuous cell-free reactors—enables rapid iteration, on-demand production, and scalable biochemistry without the need for fermentation tanks or long development cycles.

Featuring

Amy Locks

Anzen Industries

CEO

Enzyme-stabilization expert building cell-free modular “enzyme reactors.”

Jonathan Weinstein

Scala Biodesign

Prin. Scientist, Protein Design Alg. & AI

Christopher Pirie

Decycle Bio

CEO

De-novo, cell-free enzyme cascades converting waste into chemicals

Neeka Mashouf

Rubi Laboratories

CEO and Co-founder

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Kavya Sharman

Phase Capital

Managing Partner

Previous Speakers Include